Antibody responses in furunculosis patients vaccinated with autologous formalin-killed Staphylococcus aureus

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 6, 2011, Pages 707-717

  Holtfreter, S ^a,d   Jursa Kulesza, J ^b   Masiuk, H ^b   Verkaik, N J ^c   De Vogel, C ^c   Kolata, J ^a   Nowosiad, M ^b   Steil, L ^a   Van Wamel, W ^c   Van Belkum, A ^c   Volker U ^a   Giedrys Kalemba, S ^b   Broker B M ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOVACCINE; BACTERIAL ANTIGEN; FORMALDEHYDE; IMMUNOGLOBULIN G; STAPHYLOCOCCUS ANTIGEN; STAPHYLOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; AUTOVACCINATION; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CASE REPORT; CLONE; FEMALE; FLOW CYTOMETRY; FURUNCULOSIS; GENOTYPE; HUMAN; IMMUNOBLOTTING; MALE; MECA GENE; NONHUMAN; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PVL GENE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; VACCINATION;

EID: 85027946885     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-010-1136-3     Document Type: Article

References (37)

1. Dryden M (2008) Complicated skin and soft tissue infections caused by methicillin-resistant staphylococcus aureus: epidemiology, risk factors, and presentation. Surg Infect (Larchmt) 9(Supp 1):s3-s10
2. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter M, Gauduchon V, Vandenesch F, Etienne J (1999) Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 29(5):1128-1132 (Pubitemid 30265628)
3. Wertheim HF, Vos MC, Ott A, van Belkum A, Voss A, Kluytmans JA, van Keulen PH, Vandenbroucke-Grauls CM, Meester MH, Verbrugh HA (2004) Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364(9435):703-705 (Pubitemid 39140626)
4. Hay RJ, Adriaans B (2004) Bacterial infections. In: Burn T, Breathnach S, Cox N, Griffiths CE (eds) Rook's textbook of dermatology. Blackwell Publishing Company, London, United Kingdom, pp 1-85
5. Boucher HW, Corey GR (2008) Epidemiology of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 46(s5):S344-S349 (Pubitemid 351717321)
6. Schaffer AC, Lee JC (2009) Staphylococcal vaccines and immunotherapies. Infect Dis Clin North Am 23(1):153-171
7. Lindsay JA, Holden MT (2004) Staphylococcus aureus: superbug, super genome? Trends Microbiol 12(8):378-385
8. Holtfreter S, Grumann D, Schmudde M, Nguyen HT, Eichler P, Strommenger B, Kopron K, Kolata J, Giedrys-Kalemba S, Steinmetz I, Witte W, Broker BM (2007) Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol 45(8):2669-2680 (Pubitemid 47295502)
9. Novick RP, Subedi A (2007) The SaPIs: mobile pathogenicity islands of staphylococcus. Chem Immunol Allergy 93:42-57 (Pubitemid 46924871)
10. Goerke C, Pantucek R, Holtfreter S, Schulte B, Zink M, Grumann D, Broker BM, Doskar J, Wolz C (2009) Diversity of prophages in dominant Staphylococcus aureus clonal lineages. J Bacteriol 191(11):3462-3468
11. Holtfreter S, Kolata J, Broker BM (2010) Towards the immune proteome of Staphylococcus aureus - the anti-S. aureus antibody response. Int J Med Microbiol 300(2-3):176-192
12. Holtfreter S, Roschack K, Eichler P, Eske K, Holtfreter B, Kohler C, Engelmann S, Hecker M, Greinacher A, Broker BM (2006) Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J Infect Dis 193 (9):1275-1278
13. Halasa J, Giedrys-Galant S, Podkowinska I, Braun J, Strzelecka G, Dabrowski W (1978) Evaluation of certain immunological parameters in the course of autovaccine treatment in patients with chronic ostitis and carbunculosis. Arch Immunol Ther Exp (Warsz) 26(1-6):589-593
14. Wright AE (1902) Notes on the treatment of furnculosis, sycosis, and acne by the inoculation of a staphylococcus vaccine and generally on the treatment of localised bacterial invasions by therapeutic inoculations of the corresponding bacterial vaccines. Lancet 159(4100):874-884
15. Ring J, van Thiel D, Seifert J, Stickl H, Probst J, Brendel W (1976) Chronic posttraumatic osteomyelitis. Attempt at oral autovaccine therapy. Fortschr Med 94(5):264-265
16. Scott T, Scott G (1912) A record of the treatment of bacterial infections by autogenous vaccines. Lancet 879
17. Goodale RL, Mangiaracine A (1952) Clinical observations on use of autogenous vaccine made from cultures of coagulase positive hemolytic Staphylococcus aureus. Laryngoscope 62:299-311
18. Lewin J (1935) Therapy of disseminated furunculosis with autogenous and heterogenous vaccines. T Dermat Ztschr 71:85-88
19. Novotny Z, Krupicka J, Hanova I, Rys E (1990) Treatment with autovaccines and the immunologic profile of patients (in Czech). Cesk Otolaryngol 39(1):40-47
20. Cu HP, Nguyen NN, Do NT, Nguyen XH, Au XT, Van TH, Vu NQ, Dao TH (2006) A study of edema disease in pigs in Vietnam with particular reference to the use of autovaccine for the prevention of disease. Ann NY Acad Sci 1081:531-533 (Pubitemid 44968822)
21. Nolte O, Morscher J, Weiss HE, Sonntag H (2001) Autovaccination of dairy cows to treat post partum metritis caused by Actinomyces pyogenes. Vaccine 19(23-24):3146-3153 (Pubitemid 32324043)
22. Nolte O, Weiss H-E, Sonntag H-G, Hartmann S (20004) Homologe Autovakzination in der Behandlung von Infektion-skrankheiten der Pferde - Ergebnisse einer retrospektiven Erhebung. Tierärztl Umsch 59:315-320
23. Harmsen D, Claus H, Witte W, Rothganger J, Turnwald D, Vogel U (2003) Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 41 (12):5442-5448 (Pubitemid 37543228)
24. Aires-de-Sousa M, Boye K, de Lencastre H, Deplano A, Enright MC, Etienne J, Friedrich A, Harmsen D, Holmes A, Huijsdens XW, Kearns AM, Mellmann A, Meugnier H, Rasheed JK, Spalburg E, Strommenger B, Struelens MJ, Tenover FC, Thomas J, Vogel U, Westh H, Xu J, Witte W (2006) High interlaboratory reproducibility of DNA sequence-based typing of bacteria in a multicenter study. J Clin Microbiol 44(2):619-621 (Pubitemid 43222265)
25. Holtfreter S, Nguyen TT, Wertheim H, Steil L, Kusch H, Truong QP, Engelmann S, Hecker M, Volker U, van Belkum A, Broker BM (2009) Human immune proteome in experimental colonization with Staphylococcus aureus. Clin Vaccine Immunol 16 (11):1607-1614
26. Verkaik N, Brouwer E, Hooijkaas H, van Belkum A, van Wamel W (2008) Comparison of carboxylated and Penta-His microspheres for semi-quantitative measurement of antibody responses to His-tagged proteins. J Immunol Methods 335(1-2):121-125
27. Verkaik NJ, de Vogel CP, Boelens HA, Grumann D, Hoogenboezem T, Vink C, Hooijkaas H, Foster TJ, Verbrugh HA, van Belkum A, van Wamel WJ (2009) Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis 199(5):625-632
28. Masiuk H, Kopron K, Grumann D, Goerke C, Kolata J, Jursa-Kulesza J, Giedrys-Kalemba S, Broker BM, Holtfreter S (2010) Recurrent furunculosis - associations with Panton-Valentine leukocidin and the genetic background of Staphylococcus aureus. J Clin Microbiol
29. Okrasinska-Cholewa B (1994) Clinical evaluation of treating accessory nasal sinus diseases in children using autovaccine. Med Dosw Mikrobiol 46(1-2 Suppl):67-73
30. Szkaradkiewicz A, Kuch A, Korzeniowska-Kowal A, Kuzma A, Gamian A (2005) Humoral response to Staphylococcus aureus polypeptides in patients treated with autovaccine. XXIst ISTH Congress, Clin Microbiol Infect Oxford, UK
31. Bavari S, Ulrich RG, LeClaire RD (1999) Cross-reactive antibodies prevent the lethal effects of Staphylococcus aureus superantigens. J Infect Dis 180(4):1365-1369 (Pubitemid 30070230)
32. Fraser JD, Proft T (2008) The bacterial superantigen and superantigen-like proteins. Immunol Rev 225:226-243
33. Zaluga E (1998) Skin reactions to antigens of propionibacterium acnes in patients with acne vulgaris treated with autovaccine. Ann Acad Med Stetin 44:65-85
34. Rusch V, Ottendorfer D, Zimmermann K (2001) Results of an open, non-placebo controlled pilot study investigating the immunomodulatory potential of autovaccine. Arzneimittelforschung 51(8):690-697 (Pubitemid 32777681)
35. McLoughlin RM, Lee JC, Kasper DL, Tzianabos AO (2008) IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection. J Immunol 181(2):1323-1332
36. McLoughlin RM, Solinga RM, Rich J, Zaleski KJ, Cocchiaro JL, Risley A, Tzianabos AO, Lee JC (2006) CD4+ T cells and CXC chemokines modulate the pathogenesis of Staphylococcus aureus wound infections. Proc Natl Acad Sci USA 103(27):10408-10413 (Pubitemid 44051180)
37. Xia G, Kohler T, Peschel A (2009) The wall teichoic acid and lipoteichoic acid polymers of Staphylococcus aureus. Int J Med Microbiol